CS logo
small CS logo
Genesis Medical Center - East Campus

Davenport, Iowa, United States
Hospital in Davenport, Iowa
1227 E Rusholme St, Davenport, IA 52803

About Genesis Medical Center - East Campus


"Genesis Medical Center, East Rusholme Street provides comprehensive medical services including state-of-the-art operating rooms."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
42
SWOG Cancer Research Network
27
Alliance for Clinical Trials in Oncology
9
Boston Scientific Corporation
5
ECOG-ACRIN Cancer Research Group
5
NSABP Foundation Inc
4
Abbott Medical Devices
2
Medtronic Cardiac Rhythm and Heart Failure
2
NRG Oncology
2
University of Nebraska
2
Abiomed Inc.
1
Total Rows: 26

Clinical Trials at Genesis Medical Center - East Campus


During the past decade, Genesis Medical Center - East Campus conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 46 clinical trials were completed, i.e. on average, 139.4% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 19 clinical trials were completed. i.e. 211.1% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years338844336666336610101144664477Started TrialsCompleted Trails2015201620172018201920202021051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
1999-12-01
Completed
280
Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
1999-03-01
2012-12-01
Completed
5,351
S0010 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
2000-07-01
2004-07-01
Completed
35
S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
2000-11-01
2005-06-01
Completed
78
Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation
1998-12-01
2006-06-01
Completed
3,260
S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
2001-05-01
2012-11-01
Completed
95
S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome
2001-08-01
2007-01-01
Completed
130
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
2001-05-01
2011-02-01
Completed
1,598

Rows per page:

1–100 of 116

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Genesis Medical Center - East Campus" #1 sponsor was "National Cancer Institute (NCI)" with 42 trials, followed by "SWOG Cancer Research Network" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "Boston Scientific Corporation" with 5 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 26 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Genesis Medical Center - East Campus" #1 collaborator was "National Cancer Institute (NCI)" with 51 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator and "NRG Oncology" with 4 trials as a collaborator. Other collaborators include 38 different institutions and companies that were collaborators in the rest 40 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 42National CancerInstitute (NCI): 42SWOG Cancer ResearchNetwork: 27SWOG Cancer ResearchNetwork: 27Alliance for ClinicalTrials in Oncology: 9Alliance for ClinicalTrials in Oncology: 9Boston Scientific Corporation: 5Boston Scientific Corporation: 5ECOG-ACRIN CancerResearch Group: 5ECOG-ACRIN CancerResearch Group: 5NSABP Foundation Inc: 4NSABP Foundation Inc: 4Abbott Medical Devices: 2Abbott Medical Devices: 2Medtronic CardiacRhythm and HeartFailure: 2Medtronic CardiacRhythm and HeartFailure: 2NRG Oncology: 2NRG Oncology: 2University of Nebraska: 2University of Nebraska: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 51National CancerInstitute (NCI): 51Cancer and LeukemiaGroup B: 7Cancer and LeukemiaGroup B: 7SWOG Cancer ResearchNetwork: 7SWOG Cancer ResearchNetwork: 7NCIC Clinical Trials Group: 5NCIC Clinical Trials Group: 5NRG Oncology: 4NRG Oncology: 4North Central CancerTreatment Group: 4North Central CancerTreatment Group: 4Eastern CooperativeOncology Group: 3Eastern CooperativeOncology Group: 3Canadian Cancer Trials Group: 2Canadian Cancer Trials Group: 2NSABP Foundation Inc: 2NSABP Foundation Inc: 2National Institute onAging (NIA): 2National Institute onAging (NIA): 2

Clinical Trials Conditions at Genesis Medical Center - East Campus


According to Clinical.Site data, the most researched conditions in "Genesis Medical Center - East Campus" are "Breast Cancer" (8 trials), "Recurrent Breast Carcinoma" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Coronary Artery Disease" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "Genesis Medical Center - East Campus" in a lesser frequency.

Clinical Trials Intervention Types at Genesis Medical Center - East Campus


Most popular intervention types in "Genesis Medical Center - East Campus" are "Drug" (87 trials), "Other" (57 trials), "Biological" (33 trials), "Device" (15 trials) and "Procedure" (15 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (35 trials), "Quality-of-Life Assessment" (20 trials), "Paclitaxel" (13 trials), "Bevacizumab" (10 trials) and "Carboplatin" (9 trials). Other intervention names were less common.

Clinical Trials Genders at Genesis Medical Center - East Campus


The vast majority of trials in "Genesis Medical Center - East Campus" are 96 trials for "All" genders, 17 trials for "Female" genders and 3 trials for "Male" genders.

Clinical Trials Status at Genesis Medical Center - East Campus


Currently, there are NaN active trials in "Genesis Medical Center - East Campus". undefined are not yet recruiting, 13 are recruiting, 38 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Genesis Medical Center - East Campus, 1 suspended trials, and 11 terminated clinical trials to date.
Out of the total trials that were conducted in Genesis Medical Center - East Campus, 1 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 66Phase 3: 66Phase 2: 38Phase 2: 38Not Applicable: 6Not Applicable: 6Phase 4: 3Phase 4: 3Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 52Completed: 52Active, not recruiting: 38Active, not recruiting: 38Recruiting: 13Recruiting: 13Terminated: 11Terminated: 11Suspended: 1Suspended: 1Unknown status: 1Unknown status: 1

Departments of Genesis Medical Center - East Campus


Genesis Medical Center - East Campus has several departments that took part in Clinical trials: "Genesis Regional Cancer Center at Genesis Medical Center" - 60 trials, "Genesis Cancer Care Institute" - 42 trials, "Genesis Cancer Center - Silvis" - 31 trials, "Genesis Heart Institute" - 2 trials